narrowly missed significancep = 0.051
A small ( N = 31) prospective, single-arm, 24-month study using ranibizumab for the treatment of retinal angiomatous proliferation (RAP) also identified a negative correlation between age at baseline and final best-corrected VA (BCVA; R = −0.357, p = 0.049, Spearman's rho test), although when analyzed using multiple linear regression analysis it narrowly missed significance ( p = 0.051) [ 19 ].